Biogen, one of the largest biotechs in the world, said the decision to stop the study was not based on safety concerns.
لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:
Biotech company shares plummet after ending potentially groundbreaking Alzheimer's drug trial
مصر أخبار أخبار
The company said the decision to end the trial was not based on safety concerns